Prognostic value of brain injury biomarkers in acute encephalitis/ encephalopathy

Pediatrics International

Volumn 55, Issue 4, 2013, Pages 461-464

  Tsukahara, Hirokazu ^a   Fujii, Yosuke ^a   Matsubara, Kousaku ^b   Yamada, Mutsuko ^a   Nagaoka, Yoshiharu ^a   Saito, Yukie ^a   Yashiro, Masato ^a   Tsuge, Mitsuru ^a   Goto, Shinichiro ^c   Kitamura, Tetsuro ^d   Hata, Atsuko ^e   Ichiyama, Takashi ^f   Morishima, Tsuneo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NISHI KOBE MEDICAL CENTER   (Japan)

^c Kochi Health Sciences Center   (India)

^d Nippon Kokan Fukuyama Hospital   (Japan)

^e Kitano Hospital   (Japan)

^f YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

acute encephalitis encephalopathy; cerebrospinal fluid; glial fibrillary acidic protein; S 100B protein; tau protein

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S100B; TAU PROTEIN;

ACUTE ENCEPHALITIS ENCEPHALOPATHY; ADENOVIRUS; ADOLESCENT; ARTICLE; BRAIN DISEASE; BRAIN INJURY; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENCEPHALITIS; ENTEROVIRUS 71; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN HERPESVIRUS 6; INFANT; INFLUENZA VIRUS; MALE; NOROVIRUS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SURVIVOR;

ACUTE ENCEPHALITIS/ENCEPHALOPATHY; CEREBROSPINAL FLUID; GLIAL FIBRILLARY ACIDIC PROTEIN; S-100B PROTEIN; TAU PROTEIN;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS; FEMALE; FOLLOW-UP STUDIES; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INFANT; MALE; NERVE GROWTH FACTORS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; S100 PROTEINS; SEVERITY OF ILLNESS INDEX; TAU PROTEINS;

EID: 84881478250     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12094     Document Type: Article

References (13)

1. Hoshino A, Saitoh M, Oka A, et al. Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev. 2012; 34: 337-343.
2. Ichiyama T,. Acute encephalopathy/encephalitis in childhood: a relatively common and potentially devastating clinical syndrome. Brain Dev. 2010; 32: 433-434.
3. Jung K, Goerdt C, Lange P, et al. The use of S100B and Tau protein concentrations in the cerebrospinal fluid for the differential diagnosis of bacterial meningitis: a retrospective analysis. Eur. Neurol. 2011; 66: 128-132.
4. Shiihara T, Miyake T, Izumi S, et al. Serum and cerebrospinal fluid S100B, neuron-specific enolase, and total tau protein in acute encephalopathy with biphasic seizures and late reduced diffusion: a diagnostic validity. Pediatr. Int. 2012; 54: 52-55.
5. Gavhed D, Akefeldt SO, Osterlundh G, et al. Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis. Pediatr. Blood Cancer 2009; 53: 1264-1270.
6. Misu T, Takano R, Fujihara K, Takahashi T, Sato S, Itoyama Y,. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J. Neurol. Neurosurg. Psychiatry 2009; 80: 575-577.
7. Tanuma N, Miyata R, Kumada S, et al. The axonal damage marker tau protein in the cerebrospinal fluid is increased in patients with acute encephalopathy with biphasic seizures and late reduced diffusion. Brain Dev. 2010; 32: 435-439.
8. Miyata R, Tanuma N, Hayashi M, et al. Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). Brain Dev. 2012; 34: 124-127.
9. Morishima T, Togashi T, Yokota S, et al. Collaborative Study Group on Influenza-Associated Encephalopathy in Japan. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin. Infect. Dis. 2002; 35: 512-517.
10. Ichiyama T, Ito Y, Kubota M, Yamazaki T, Nakamura K, Furukawa S,. Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection. Brain Dev. 2009; 31: 731-738.
11. Ichiyama T, Morishima T, Kajimoto M, Matsushige T, Matsubara T, Furukawa S,. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr. Infect. Dis. J. 2007; 26: 542-544.
12. Yamanaka G, Kawashima H, Suganami Y, et al. Diagnostic and predictive value of CSF d-ROM level in influenza virus-associated encephalopathy. J. Neurol. Sci. 2006; 243: 71-75.
13. Sanayama Y, Nagasaka H, Takayanagi M, et al. Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Mol. Genet. Metab. 2011; 103: 220-225.